MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s00277-023-05405-0

Медицинская библиотека · Annals of hematology · 2023

Dominant-negative type of IKZF1 deletion showed a favorable prognosis in adult B-cell acute lymphoblastic leukemia.

Kimura Hiroyuki, Onozawa Masahiro, Yoshida Shota, Miyashita Naoki, Yokoyama Shota, Matsukawa Toshihiro, Hirabayashi Shinsuke, Goto Hideki, Endo Tomoyuki, Oguri Satoshi, Fujisawa Shinichi, Mori Akio, Kondo Takeshi, Hidaka Daisuke, Okada Kohei, Ota Shuichi, Kakinoki Yasutaka, Tsutsumi Yutaka, Yamamoto Satoshi, Miyagishima Takuto, Hashiguchi Junichi, Nagashima Takahiro, Ibata Makoto, Wakasa Kentaro, Haseyama Yoshihito, Fujimoto Katsuya, Ishihara Toshimichi, Sakai Hajime, Teshima Takanori

СтатьяНаблюдательное исследованиеПеревод пока не подготовлен

Аннотация

IKZF1 deletion is a recurrent genomic alteration in B-cell acute lymphoblastic leukemia (B-ALL) and is divided into dominant-negative (DN) and loss of function (LOF) deletions. The prognostic impact of each deletion has not been fully elucidated. We retrospectively analyzed 117 patients with adult B-ALL including 60 patients with BCR::ABL1-positive B-ALL and 57 patients with BCR::ABL1-negative B-ALL by the fluorescence in situ hybridization (FISH) method for IKZF1 deletion and multiplex PCR for the 4 most common IKZF1 deletions (∆4-7, ∆2-7, ∆2-8, and ∆4-8). Samples, in which IKZF1 deletion was detected by FISH but a specific type of deletion was not identified by the PCR, were categorized as "other." Patients were classified into a DN group that had at least 1 allele of ∆4-7 (n = 23), LOF and other group (n = 40), and wildtype group (n = 54). DN type IKZF1 deletions were found in 33.3% of BCR::ABL1-positive cases and 5.2% of BCR::ABL1-negative cases. LOF and other type IKZF1 deletions were found in 43.4% of BCR::ABL1-positive cases and 24.6% of BCR::ABL1-negative cases. Patients with the DN group showed significantly higher overall survival (OS) than that of the LOF and other and WT groups (P = 0.011). Multivariate analysis including age, WBC counts, complex karyotype, and DN type IKZF1 deletion showed that the DN type of IKZF1 deletion (HR = 0.22, P = 0.013) had a positive impact and age ≥ 65 (HR = 1.92, P = 0.029) had a negative impact on OS. The prognostic impact of IKZF1 deletion depends on the type of deletion and DN type of IKZF1 deletion showed better prognosis in adult B-ALL patients.Clinical trial registration This study was part of a prospective observational study (Hokkaido Leukemia Net, UMIN000048611). It was conducted in compliance with ethical principles based on the Helsinki Declaration and was approved by the institutional review board of Hokkaido University Hospital (#015-0344).

Для цитирования: Kimura Hiroyuki, Onozawa Masahiro, Yoshida Shota, Miyashita Naoki, Yokoyama Shota, Matsukawa Toshihiro, Hirabayashi Shinsuke, Goto Hideki, Endo Tomoyuki, Oguri Satoshi, Fujisawa Shinichi, Mori Akio, Kondo Takeshi, Hidaka Daisuke, Okada Kohei, Ota Shuichi, Kakinoki Yasutaka, Tsutsumi Yutaka, Yamamoto Satoshi, Miyagishima Takuto, Hashiguchi Junichi, Nagashima Takahiro, Ibata Makoto, Wakasa Kentaro, Haseyama Yoshihito, Fujimoto Katsuya, Ishihara Toshimichi, Sakai Hajime, Teshima Takanori. Dominant-negative type of IKZF1 deletion showed a favorable prognosis in adult B-cell acute lymphoblastic leukemia.. Annals of hematology. 2023. DOI: 10.1007/s00277-023-05405-0.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.